RU2017115114A - Фармацевтическая композиция вакцины для чрескожного введения - Google Patents
Фармацевтическая композиция вакцины для чрескожного введения Download PDFInfo
- Publication number
- RU2017115114A RU2017115114A RU2017115114A RU2017115114A RU2017115114A RU 2017115114 A RU2017115114 A RU 2017115114A RU 2017115114 A RU2017115114 A RU 2017115114A RU 2017115114 A RU2017115114 A RU 2017115114A RU 2017115114 A RU2017115114 A RU 2017115114A
- Authority
- RU
- Russia
- Prior art keywords
- vaccine
- pharmaceutical composition
- percutaneous administration
- antigen
- administration according
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 9
- 229960005486 vaccine Drugs 0.000 title claims 9
- 230000005540 biological transmission Effects 0.000 title 1
- 239000000427 antigen Substances 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 229960001438 immunostimulant agent Drugs 0.000 claims 3
- 239000003022 immunostimulating agent Substances 0.000 claims 3
- 230000003308 immunostimulating effect Effects 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 241000572738 Roseomonas Species 0.000 claims 2
- 239000000853 adhesive Substances 0.000 claims 2
- 230000001070 adhesive effect Effects 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 241000589220 Acetobacter Species 0.000 claims 1
- 241000590020 Achromobacter Species 0.000 claims 1
- 241001502776 Acidicaldus Species 0.000 claims 1
- 241000588853 Acidiphilium Species 0.000 claims 1
- 241000501787 Acidisphaera Species 0.000 claims 1
- 241000501828 Acidocella Species 0.000 claims 1
- 241001478307 Acidomonas Species 0.000 claims 1
- 241000308413 Asaia Species 0.000 claims 1
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 241001459699 Belnapia Species 0.000 claims 1
- 241000193403 Clostridium Species 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 241001302396 Craurococcus Species 0.000 claims 1
- 241000588914 Enterobacter Species 0.000 claims 1
- 241000589565 Flavobacterium Species 0.000 claims 1
- 241000032681 Gluconacetobacter Species 0.000 claims 1
- 241000589236 Gluconobacter Species 0.000 claims 1
- 241001657403 Kozakia Species 0.000 claims 1
- 241001500096 Leahibacter Species 0.000 claims 1
- 241001647840 Leclercia Species 0.000 claims 1
- 241000193751 Methanoculleus Species 0.000 claims 1
- 241000205276 Methanosarcina Species 0.000 claims 1
- 241000192041 Micrococcus Species 0.000 claims 1
- 241001604462 Neoasaia Species 0.000 claims 1
- 241001610718 Oleomonas Species 0.000 claims 1
- 241000520272 Pantoea Species 0.000 claims 1
- 241001302159 Paracraurococcus Species 0.000 claims 1
- 241000589516 Pseudomonas Species 0.000 claims 1
- 241001478280 Rahnella Species 0.000 claims 1
- 241000190937 Rhodopila Species 0.000 claims 1
- 241001495145 Roseococcus Species 0.000 claims 1
- 241001063175 Rubritepida Species 0.000 claims 1
- 241000602127 Saccharibacter Species 0.000 claims 1
- 241000607720 Serratia Species 0.000 claims 1
- 241000862969 Stella Species 0.000 claims 1
- 241001248469 Swaminathania Species 0.000 claims 1
- 241000589634 Xanthomonas Species 0.000 claims 1
- 241001185312 Zavarzinia Species 0.000 claims 1
- 241000588901 Zymomonas Species 0.000 claims 1
- 239000012790 adhesive layer Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000002158 endotoxin Substances 0.000 claims 1
- 230000004727 humoral immunity Effects 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 229920006008 lipopolysaccharide Polymers 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Claims (8)
1. Фармацевтическая композиция вакцины для чрескожного введения, предназначенная для введения через кожу человека или животного, содержащая: липополисахарид, полученный по меньшей мере из одной грамотрицательной бактерии, выбранной из группы, состоящей из Serratia, Leclercia, Rahnella, Acidicaldus, Acidiphilium, Acidisphaera, Acidocella, Acidomonas, Asaia, Belnapia, Craurococcus, Gluconacetobacter, Gluconobacter, Kozakia, Leahibacter, Muricoccus, Neoasaia, Oleomonas, Paracraurococcus, Rhodopila, Roseococcus, Rubritepida, Saccharibacter, Стелла, Swaminathania, Teichococcus, Zavarzinia, Pseudomonas, Achromobacter, Bacillus, Methanoculleus, Methanosarcina, Clostridium, Micrococcus, Flavobacterium, Pantoea, Acetobacter, Zymomonas, Xanthomonas и Enterobacter, или его соль в качестве иммуностимулятора; и по меньшей мере один антиген,
причем соотношение массы иммуностимулятора и антигена в указанной фармацевтической композиции вакцины, а именно общая масса иммуностимулятора/общая масса антигена, составляет от 0,002 до 500.
2. Фармацевтическая композиция вакцины для чрескожного введения по п.1, которая представлена в лекарственной форме пластыря.
3. Фармацевтическая композиция вакцины для чрескожного введения по п.2, отличающаяся тем, что пластырь включает подложку и клейкий слой, содержащий адгезив, и указанный адгезив содержит основу из гидрофильного материала.
4. Фармацевтическая композиция вакцины для чрескожного введения по пп.1-3, которая используется для индукции гуморального иммунитета.
5. Фармацевтическая композиция вакцины для чрескожного введения по пп.1-3, которая используется для профилактики инфекционного заболевания.
6. Фармацевтическая композиция вакцины для чрескожного введения по пп.1-3, которая используется для профилактики или лечения рака.
7. Фармацевтическая композиция вакцины для чрескожного введения по пп.1-4, в которой одним из антигенов является по меньшей мере антиген инфекционного происхождения и раковый антиген.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014-204020 | 2014-10-02 | ||
| JP2014204020 | 2014-10-02 | ||
| PCT/JP2015/077921 WO2016052698A1 (ja) | 2014-10-02 | 2015-10-01 | 経皮投与用ワクチン医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2017115114A true RU2017115114A (ru) | 2018-11-05 |
Family
ID=55630719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017115114A RU2017115114A (ru) | 2014-10-02 | 2015-10-01 | Фармацевтическая композиция вакцины для чрескожного введения |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10420837B2 (ru) |
| EP (1) | EP3202417A4 (ru) |
| JP (1) | JP2016074654A (ru) |
| KR (1) | KR20170055487A (ru) |
| CN (1) | CN106714827A (ru) |
| BR (1) | BR112017006599A2 (ru) |
| CA (1) | CA2960940A1 (ru) |
| RU (1) | RU2017115114A (ru) |
| TW (1) | TW201618790A (ru) |
| WO (1) | WO2016052698A1 (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201618790A (zh) * | 2014-10-02 | 2016-06-01 | Nitto Denko Corp | 經皮投與用疫苗醫藥組合物 |
| JP6995468B2 (ja) * | 2016-08-30 | 2022-01-14 | 有限会社バイオメディカルリサーチグループ | ダームシジン誘導剤 |
| JP6998133B2 (ja) * | 2017-05-28 | 2022-01-18 | 自然免疫制御技術研究組合 | リポ多糖を用いた脳機能改善剤、食品及び医薬品 |
| CN110960675B (zh) * | 2019-12-17 | 2024-02-06 | 天康生物制药有限公司 | 仔猪腹泻防控用肚脐贴片疫苗及其制备方法 |
| JP7414385B1 (ja) | 2023-04-24 | 2024-01-16 | 源一郎 杣 | リポ多糖、リポ多糖製造方法及びリポ多糖配合物 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2849950B2 (ja) * | 1990-11-30 | 1999-01-27 | 日東電工株式会社 | 経皮吸収製剤 |
| JP2002537351A (ja) * | 1999-02-22 | 2002-11-05 | ユニバーシティ・オブ・ブリティッシュ・コロンビア | コーロバクターリポ多糖免疫アジュバント |
| GB0103169D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| WO2005027964A1 (en) * | 2003-09-15 | 2005-03-31 | Id Biomedical Corporation Of Quebec | Measles subunit vaccine |
| US20070243132A1 (en) * | 2005-12-22 | 2007-10-18 | Apollo Life Sciences Limited | Transdermal delivery of pharmaceutical agents |
| EP2116256A1 (en) * | 2007-03-01 | 2009-11-11 | Cosmed Pharmaceutical Co., Ltd. | Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same |
| US20090010998A1 (en) * | 2007-07-03 | 2009-01-08 | Marchitto Kevin S | Drug-delivery patch comprising a dissolvable layer and uses thereof |
| JP5190628B2 (ja) | 2008-03-31 | 2013-04-24 | 一般財団法人阪大微生物病研究会 | 混合免疫賦活剤を含む新規ワクチン |
| JP5841433B2 (ja) * | 2012-01-11 | 2016-01-13 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
| JP5650780B2 (ja) | 2012-04-04 | 2015-01-07 | 日東電工株式会社 | ワクチン組成物 |
| KR20140100415A (ko) * | 2013-02-05 | 2014-08-14 | 닛토덴코 가부시키가이샤 | 경피 투여용 백신 조성물 |
| RU2685933C2 (ru) | 2013-02-05 | 2019-04-23 | Нитто Денко Корпорейшн | Композиция противораковой вакцины, содержащая пептид wt1, для трансдермального введения |
| KR20140099828A (ko) * | 2013-02-05 | 2014-08-13 | 닛토덴코 가부시키가이샤 | 점막 투여용 백신 조성물 |
| US10449144B2 (en) * | 2013-02-05 | 2019-10-22 | Nitto Denko Corporation | WT1 peptide cancer vaccine composition for transdermal administration |
| CN103961698A (zh) * | 2013-02-05 | 2014-08-06 | 日东电工株式会社 | 经皮或粘膜给予用疫苗组合物 |
| KR20140100417A (ko) * | 2013-02-05 | 2014-08-14 | 닛토덴코 가부시키가이샤 | 경피 투여용 백신 조성물 |
| IN2014CH00393A (ru) * | 2013-02-05 | 2015-04-03 | Nitto Denko Corp | |
| EP2762155B1 (en) * | 2013-02-05 | 2020-03-11 | Nitto Denko Corporation | Vaccine Composition |
| US10017545B2 (en) * | 2013-06-03 | 2018-07-10 | University Of Maryland, College Park | Compositions and vaccines comprising vesicles and methods of using the same |
| JP2015091794A (ja) * | 2013-10-03 | 2015-05-14 | 日東電工株式会社 | 注射ワクチン組成物 |
| WO2015050178A1 (ja) * | 2013-10-03 | 2015-04-09 | 日東電工株式会社 | 鼻粘膜ワクチン組成物 |
| JP6494233B2 (ja) * | 2013-10-03 | 2019-04-03 | 日東電工株式会社 | 粘膜ワクチン組成物 |
| HK1219054A1 (zh) * | 2013-10-03 | 2017-03-24 | 日东电工株式会社 | 粘膜疫苗组合物 |
| US10369219B2 (en) * | 2014-08-04 | 2019-08-06 | Nitto Denko Corporation | Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition |
| JP6574556B2 (ja) * | 2014-08-27 | 2019-09-11 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
| CN106687138B (zh) * | 2014-09-03 | 2021-10-15 | 日东电工株式会社 | 包含双膦酸盐剂的细胞性免疫用疫苗药物组合物 |
| TW201618790A (zh) * | 2014-10-02 | 2016-06-01 | Nitto Denko Corp | 經皮投與用疫苗醫藥組合物 |
| BR112017022585A2 (pt) * | 2015-05-01 | 2018-07-17 | Nitto Denko Corporation | composição de vacina de alergia |
| EP3332809A4 (en) * | 2015-08-06 | 2019-04-10 | Nitto Denko Corporation | COMPOSITION FOR IMMUNITY INDUCTION PROMOTION AND PHARMACEUTICAL VACCINE COMPOSITION |
| US10744197B2 (en) * | 2015-11-27 | 2020-08-18 | Nitto Denko Corporation | Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration |
-
2015
- 2015-10-01 TW TW104132439A patent/TW201618790A/zh unknown
- 2015-10-01 JP JP2015195689A patent/JP2016074654A/ja active Pending
- 2015-10-01 WO PCT/JP2015/077921 patent/WO2016052698A1/ja not_active Ceased
- 2015-10-01 RU RU2017115114A patent/RU2017115114A/ru unknown
- 2015-10-01 CN CN201580052013.6A patent/CN106714827A/zh active Pending
- 2015-10-01 KR KR1020177007133A patent/KR20170055487A/ko not_active Withdrawn
- 2015-10-01 BR BR112017006599A patent/BR112017006599A2/pt not_active Application Discontinuation
- 2015-10-01 EP EP15846575.7A patent/EP3202417A4/en not_active Ceased
- 2015-10-01 CA CA2960940A patent/CA2960940A1/en not_active Abandoned
- 2015-10-01 US US15/514,868 patent/US10420837B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US10420837B2 (en) | 2019-09-24 |
| KR20170055487A (ko) | 2017-05-19 |
| BR112017006599A2 (pt) | 2017-12-19 |
| CN106714827A (zh) | 2017-05-24 |
| US20170216431A1 (en) | 2017-08-03 |
| EP3202417A1 (en) | 2017-08-09 |
| TW201618790A (zh) | 2016-06-01 |
| EP3202417A4 (en) | 2018-04-25 |
| WO2016052698A1 (ja) | 2016-04-07 |
| JP2016074654A (ja) | 2016-05-12 |
| CA2960940A1 (en) | 2016-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017115114A (ru) | Фармацевтическая композиция вакцины для чрескожного введения | |
| Lopez et al. | Killed oral cholera vaccines: history, development and implementation challenges | |
| RU2434638C2 (ru) | Вакцина альфа токсоида с.perfringens | |
| PH12021550318A1 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| JP2014532620A5 (ru) | ||
| EP4218813A3 (en) | High concentration anti-c5 antibody formulations | |
| TW200722101A (en) | Novel composition | |
| WO2017123636A8 (en) | Dosage and administration of anti-c5 antibodies for treatment | |
| AR064009A1 (es) | Metodo de inmunizacion contra los 4 serotipos del dengue | |
| RU2016109363A (ru) | Инъекционная вакцинная композиция | |
| RU2013114980A (ru) | Вакцинная композиция | |
| EA200900024A1 (ru) | Противогриппозная вакцина | |
| RU2017124240A (ru) | СПОСОБ ПОЛУЧЕНИЯ ГОТОВОЙ К ПРИМЕНЕНИЮ КОМБИНИРОВАННОЙ ВАКЦИНЫ ПРОТИВ PCV2/M.hyo | |
| MX390304B (es) | Proceso para preparar una vacuna tetravalente atenuada contra el dengue. | |
| CL2008003845A1 (es) | Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina. | |
| MX2016003325A (es) | Composicion de vacuna para mucosa. | |
| RU2016109366A (ru) | Назальная мукозальная вакцинная композиция | |
| RU2017141745A (ru) | Вакцинная композиция против аллергии | |
| Ibarra‐Moreno et al. | Coadministration of protoxin C ry1 A c from B acillus thuringiensis with metacestode extract confers protective immunity to murine cysticercosis | |
| AR065765A1 (es) | Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias | |
| NO20090290L (no) | Polyvalent vaksine mot salmonid alfavirusinfeksjoner | |
| BR112016006245A2 (pt) | composição de vacina de mucosa | |
| CL2020002876A1 (es) | Vacuna contra la bronquitis infecciosa (divisional de la solicitud no. 201803420) | |
| CO6511241A2 (es) | Régimen de inmunizaión por sensibilización-refuerzo heteróloga | |
| WO2017178660A9 (en) | Chagas antigens and antibodies and compositions, methods and uses thereof |